Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

Amanda Leach and colleagues compare two pneumococcal conjugate vaccines to examine the impact on hearing loss

Related Keywords

United States ,Australia ,Northern Territory ,Australian , ,Government Hearing Health Program ,Centre Of Research Excellence ,Research Council Clinical Trial Centre ,Wa Aboriginal Health Ethics Committee ,World Health Organization ,Hearing For Learning Initiative ,Astrazeneca ,Vaccines For Otitis In Children Entering School ,European Respiratory Society ,Menzies School Of Health Research ,Wa Department Of Health ,National Health ,Research Council ,Australian Aboriginal Health Ethics Committee ,Glaxosmithkline ,Pearson ,First Nations ,Australian First Nations ,Creative Commons Attribution License ,Senior Data Manager ,Menzies School ,Health Research ,Health Ethics Committee ,Menzie Child ,Maternal Health Division ,Australian First Nations Reference ,Medical Research Council ,Chief Investigators ,Associate Investigators ,Merck Sharp ,Data Safety Monitoring Board ,Research Excellence ,Medical Research ,European Respiratory ,Visual Reinforcement Observation Audiometry ,Otitis In Children Entering School ,Consolidated Standards ,Reporting Trials ,Western Australian ,Medical Research Council Clinical Trial Centre ,Hearing Health Program ,Play Audiometry ,Hearing Australia ,Clinical Nurse Specialist ,Learning Initiative ,Human Research Ethics Committees ,Northern Territory Department ,Central Australian ,Data Safety ,Monitoring Board ,Open Access ,